美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Valion Bio Inc

0.1590

-0.0070-4.22%

盤後：0.1547-0.0043-2.70%16:56 EDT

成交量：717.25萬

成交額：107.59萬

市值：352.82萬

市盈率：-0.02

高：0.1626

開：0.1450

低：0.1400

收：0.1660

52周最高：3.21

52周最低：0.1116

股本：2,218.97萬

流通股本：2,211.64萬

量比：0.25

換手率：32.43%

股息：- -

股息率：- -

每股收益(TTM):-8.0382

每股收益(LYR):-7.6830

淨資產收益率：-459.52%

總資產收益率：-57.13%

市淨率：0.83

市盈率(LYR):-0.02

資料載入中...

總覽公司新聞資訊公告

Valion Bio突發人事變動：CEO Michael K. Handley被解職，8月16日正式生效

烏克蘭衞生部依據監管等效路徑正式受理Entolimod檔案進行審評

Afrri/Niaid 設計專有PBI-BM2.5方案，評估Valion Bio（納斯達克：VBIO）的Entolimod作為首個且唯一GI-ARS療法

Valion Bio獲美國國家過敏和傳染病研究所首項FDA先例研究方案用於Entolimod™；聯邦機構將全額資助BLA啓動物體內研究計劃並共同推進FDA申報

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrdive.com/hant/stock/VBIO/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"VBIO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VBIO\",,,,,undefined,":{"symbol":"VBIO","market":"US","secType":"STK","nameCN":"Valion Bio Inc","latestPrice":0.159,"timestamp":1787688000000,"preClose":0.166,"halted":0,"volume":7172547,"hourTrading":{"tag":"盘后","latestPrice":0.1547,"preClose":0.159,"latestTime":"16:56 EDT","volume":106066,"amount":16493.406189100002,"timestamp":1787691417706,"change":-0.0043,"changeRate":-0.027044,"amplitude":0.033333},"delay":0,"changeRate":-0.04216867469879522,"floatShares":22116363,"shares":22189739,"eps":-8.0382,"marketStatus":"盤後交易","change":-0.007,"latestTime":"08-25 17:02:39 EDT","open":0.145,"high":0.1626,"low":0.14,"amount":1075863.1862013899,"amplitude":0.136145,"askPrice":0.16,"askSize":7911,"bidPrice":0.146,"bidSize":1000,"shortable":0,"etf":0,"ttmEps":-8.0382,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1787702400000},"marketStatusCode":4,"adr":0,"listingDate":1636606800000,"exchange":"NASDAQ","adjPreClose":0.166,"preHourTrading":{"tag":"盘前","latestPrice":0.1459,"preClose":0.166,"latestTime":"09:28 EDT","volume":901515,"amount":126463.7488971,"timestamp":1787664531059,"change":-0.0201,"changeRate":-0.121084,"amplitude":0.087952},"postHourTrading":{"tag":"盘后","latestPrice":0.1547,"preClose":0.159,"latestTime":"16:56 EDT","volume":106066,"amount":16493.406189100002,"timestamp":1787691417706,"change":-0.0043,"changeRate":-0.027044,"amplitude":0.033333},"volumeRatio":0.252797},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VBIO\",,,,,undefined,":{"symbol":"VBIO","floatShares":22116363,"roa":"-57.13%","roe":"-459.52%","lyrEps":-7.683047,"volumeRatio":0.252797,"shares":22189739,"dividePrice":0,"high":0.1626,"amplitude":0.136145,"preClose":0.166,"low":0.14,"week52Low":0.1116,"pbRate":"0.83","psRate":"-41.03","week52High":3.2077,"institutionHeld":0,"latestPrice":0.159,"committee":-0.775558,"eps":-8.0382,"divideRate":0,"volume":7172547,"delay":0,"ttmEps":-8.0382,"open":0.145,"prevYearClose":1.45,"prevWeekClose":0.1226,"prevMonthClose":0.31,"prevQuarterClose":0.5199,"fiveDayClose":0.1606,"twentyDayClose":0.2878,"sixtyDayClose":0.766},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/VBIO\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"VBIO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"VBIO\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/VBIO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"VBIO","date":"2026-08-24","current":-0.019283,"percent":0.384615,"low":-0.392475,"twenty":-0.201902,"median":-0.127297,"eighty":-0.068529,"high":-0.027033,"avg":-0.151588,"sd":0.092251,"marketCap":2720462},"quantilePoints":[{"date":"2026-04-30","current":-0.311197,"twenty":-0.324163,"median":-0.319301,"eighty":-0.314439,"marketCap":2762808},{"date":"2026-05-08","current":-0.33713,"twenty":-0.336482,"median":-0.327405,"eighty":-0.314439,"marketCap":2993043},{"date":"2026-05-15","current":-0.329149,"twenty":-0.341701,"median":-0.33551,"eighty":-0.327405,"marketCap":2922183},{"date":"2026-05-22","current":-0.203146,"twenty":-0.339301,"median":-0.327405,"eighty":-0.203206,"marketCap":2758322},{"date":"2026-05-29","current":-0.18116,"twenty":-0.338751,"median":-0.311197,"eighty":-0.201597,"marketCap":2459794},{"date":"2026-06-05","current":-0.173392,"twenty":-0.33713,"median":-0.203331,"eighty":-0.18116,"marketCap":2354321},{"date":"2026-06-12","current":-0.138668,"twenty":-0.333889,"median":-0.20236,"eighty":-0.175704,"marketCap":1882829},{"date":"2026-06-18","current":-0.131547,"twenty":-0.330097,"median":-0.198754,"eighty":-0.158647,"marketCap":1786145},{"date":"2026-06-26","current":-0.136114,"twenty":-0.327754,"median":-0.18598,"eighty":-0.135201,"marketCap":1848155},{"date":"2026-07-02","current":-0.122229,"twenty":-0.327405,"median":-0.179125,"eighty":-0.130362,"marketCap":1659627},{"date":"2026-07-10","current":-0.117868,"twenty":-0.31768,"median":-0.175704,"eighty":-0.126637,"marketCap":1600412},{"date":"2026-07-17","current":-0.115133,"twenty":-0.303417,"median":-0.165705,"eighty":-0.121795,"marketCap":1563282},{"date":"2026-07-24","current":-0.06742,"twenty":-0.241361,"median":-0.149117,"eighty":-0.119839,"marketCap":915435},{"date":"2026-07-31","current":-0.065535,"twenty":-0.203355,"median":-0.136114,"eighty":-0.117713,"marketCap":889829},{"date":"2026-08-07","current":-0.064804,"twenty":-0.203188,"median":-0.130843,"eighty":-0.108033,"marketCap":879906},{"date":"2026-08-14","current":-0.040264,"twenty":-0.202832,"median":-0.129351,"eighty":-0.073786,"marketCap":546700},{"date":"2026-08-21","current":-0.027033,"twenty":-0.202055,"median":-0.126472,"eighty":-0.068316,"marketCap":506868},{"date":"2026-08-24","current":-0.145091,"twenty":-0.201902,"median":-0.127297,"eighty":-0.068529,"marketCap":2720462}],"updateTime":1787673196293},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"VBIO\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1135704668","title":"Valion Bio突發人事變動：CEO Michael K. Handley被解職，8月16日正式生效","url":"https://stock-news.laohu8.com/highlight/detail?id=1135704668","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135704668?lang=zh_tw&edition=fundamental","pubTime":"2026-08-17 18:13","pubTimestamp":1786961590,"startTime":"0","endTime":"0","summary":"据美国证券交易委员会最新披露的文件显示，Valion Bio公司首席执行官Michael K. Handley已被终止职务，该决定将于今年8月16日正式生效。作为一家生物科技企业，Valion Bio在业内一直备受关注，而此番高层变动无疑为公司的未来走向增添了新的不确定性。不过，截至目前，公司方面尚未就此次人事变动的具体原因作出进一步说明。Valion Bio接下来如何平稳过渡、谁将接任这一关键职位，都将成为市场关注的焦点。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VBIO","BK4082","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108799602","title":"烏克蘭衞生部依據監管等效路徑正式受理Entolimod檔案進行審評","url":"https://stock-news.laohu8.com/highlight/detail?id=1108799602","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108799602?lang=zh_tw&edition=fundamental","pubTime":"2026-07-22 19:46","pubTimestamp":1784720777,"startTime":"0","endTime":"0","summary":"乌克兰卫生部已正式接受Entolimod（一种用于治疗急性辐射综合征的候选药物）的注册档案，并依据其监管等效性路径启动正式审评程序。此举标志着该药物在乌克兰的监管审批进程迈出了关键一步。\nEntolimod由Valion Bio Inc开发，此次档案受理意味着该药物在乌克兰的上市申请已进入实质性审查阶段。监管等效性路径允许乌克兰主管部门参考其他严格监管机构（如美国FDA或欧洲EMA）的审评数据与决策，以加速本国审批流程。\n这一进展为Entolimod未来在乌克兰市场的潜在获批奠定了基础，也为Valion Bio Inc拓展其全球布局提供了新的监管机遇。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4082","VBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161118562","title":"Afrri/Niaid 設計專有PBI-BM2.5方案，評估Valion Bio（納斯達克：VBIO）的Entolimod作為首個且唯一GI-ARS療法","url":"https://stock-news.laohu8.com/highlight/detail?id=1161118562","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161118562?lang=zh_tw&edition=fundamental","pubTime":"2026-06-25 19:46","pubTimestamp":1782387982,"startTime":"0","endTime":"0","summary":"美国陆军放射生物学研究所与国立过敏和传染病研究所联合设计了一项专有的PBI-BM2.5研究方案，旨在评估Valion Bio Inc（纳斯达克股票代码：VBIO）旗下药物Entolimod，将其作为首个也是目前唯一用于治疗胃肠道急性辐射综合征的候选疗法。这项专门设计的方案旨在验证该药物的有效性与安全性，标志着针对这一严重辐射损伤的治疗开发迈出了关键一步。若最终评估结果积极，Entolimod有望填补该治疗领域长期存在的空白，为受辐射影响的胃肠道系统提供首个靶向治疗方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VBIO","BK4082","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120053939","title":"Valion Bio獲美國國家過敏和傳染病研究所首項FDA先例研究方案 用於Entolimod™；聯邦機構將全額資助BLA啓動物體內研究計劃並共同推進FDA申報","url":"https://stock-news.laohu8.com/highlight/detail?id=1120053939","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120053939?lang=zh_tw&edition=fundamental","pubTime":"2026-05-05 20:01","pubTimestamp":1777982492,"startTime":"0","endTime":"0","summary":"Valion Bio公司宣布，已从美国国家过敏和传染病研究所获得针对Entolimod™的首个FDA先例研究方案。这一重要进展标志着联邦机构将全面资助该公司开展生物制品许可申请相关的动物体内研究项目，并将协同推进FDA申报流程。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","VBIO"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":4,"code":"91000000","status":"200"}]}}